Peptide Therapeutics intermediate
ALRN-6924 - MDM2/MDMX (NCT04022876)
Phase II trial of ALRN-6924 for MDM2/MDMX-driven cancers. This peptide or oligopeptide is studied for its biological activity, structure-activity relationshi...
By Encyclopeptide Editorial | 1 min read
alrn-6924-mdm2-mdmx-nct04022876 peptide research
Overview
Phase II trial of ALRN-6924 for MDM2/MDMX-driven cancers.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “ALRN-6924 - MDM2/MDMX (NCT04022876)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about ALRN-6924 - MDM2/MDMX (NCT04022876) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept